Federal Trade Commission Chair Lina Khan has continuously pushed policies that threaten free markets and American prosperity. One of her most troubling actions is using taxpayer dollars to assist the European Union in implementing its Digital Markets Act (DMA), a regulatory scheme that targets U.S. tech companies like Amazon, Apple, Read more…
In his latest article for RealClear Health, Market Institute President Charles Sauer highlights the importance of preserving patient choice in healthcare. As the CDC’s Advisory Committee on Immunization Practices (ACIP) prepares to vote on lowering the age for routine pneumococcal vaccinations, Sauer argues that both FDA-approved vaccines should be recommended. Read more…
Current antitrust actions led by figures like FTC Chair Lina Khan and Senator JD Vance threaten not only the success of these companies but also the fundamental freedoms they enable. Khan’s aggressive stance against Big Tech, particularly her push to break up or heavily regulate tech giants, reflects a disturbing Read more…
The Federal Trade Commission (FTC) under Lina Khan and the Justice Department’s Antitrust Division, led by Jonathan Kanter, are intensifying their focus on what they term “serial acquirers.” These are companies that grow by acquiring or merging with smaller businesses, often in the same industry. Khan and Kanter, as leading Read more…
In the vast landscape of internet regulation, few laws have been as influential—or as controversial—as Section 230 of the Communications Decency Act of 1996. At the heart of this debate are 26 words that have shaped the digital age: “No provider or user of an interactive computer service shall be Read more…
In the world of e-commerce, few names resonate as strongly as Amazon. Starting from humble beginnings in a Seattle garage, Jeff Bezos transformed his online bookstore into the globe-spanning retail giant we know today. The secret behind Amazon’s success lies in its blend of competitive pricing, extensive product selection, and Read more…
In recent years, the Federal Trade Commission (FTC) has taken a notably aggressive stance on mergers and acquisitions under the leadership of Chair Lina Khan. This has sparked widespread debate and concern among various stakeholders in the business community. US Policy Editor Charles Sauer delves into the impact of Khan’s Read more…
Public figures often use a tactic called the non-denial denial to avoid giving straight answers to tough questions. FTC Chair Lina Khan showcased this technique during her testimony before a House Appropriations Subcommittee, where she was questioned about the FTC’s aggressive antitrust policies and international collaborations. In his article, Market Read more…
In an age where technology plays an increasingly crucial role in our daily lives and industries, the importance of innovation cannot be overstated. However, current legislative moves in Congress are threatening to stifle a significant part of this progress due to an overreaction toward Chinese technology companies. In the article Read more…
The recent Congressional hearing on drug prices, patents, and the pharmaceutical industry has ignited a fervent debate. Unfortunately, much of the discourse has been overshadowed by misunderstandings and misinformation. A nuanced comprehension of the patent system and its pivotal role in drug innovation is essential for fostering informed discussions and Read more…